Christopher James | executive |
Michael Heffernan | executive |
Colleen Tupper | executive |
Scott Dreyer | executive |
David Amsellem | analyst |
Leszek Sulewski | analyst |
Greetings, and welcome to the Collegium Pharmaceutical Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium. Thank you.
You may begin.